{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:17:32Z","timestamp":1787987852054,"version":"build-2784847793"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T00:00:00Z","timestamp":1395100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/nrneph.2014.38","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T13:37:06Z","timestamp":1395149826000},"page":"279-289","source":"Crossref","is-referenced-by-count":79,"title":["Renal involvement in antiphospholipid syndrome"],"prefix":"10.1038","volume":"10","author":[{"given":"Savino","family":"Sciascia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munther","family":"Khamashta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"key":"BFnrneph201438_CR1","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","volume":"287","author":"GR Hughes","year":"1983","unstructured":"Hughes, G. R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br. Med. J. (Clin. Res. Ed.) 287, 1088\u20131089 (1983).","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"BFnrneph201438_CR2","first-page":"75","volume-title":"Autoantibodies","author":"M Khamashta","year":"2013","unstructured":"Khamashta, M., Sciascia, S. & Bertolaccini, M. L. in Autoantibodies Vol 1 3rd edition (eds Shoenfeld, Y., Meroni, P. & Gershwin, M.) 75\u201398 (Elsevier, 2013)."},{"key":"BFnrneph201438_CR3","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson, W. A. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42, 1309\u20131311 (1999).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201438_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis, S. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4, 295\u2013306 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrneph201438_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/1-84628-009-5_3","volume-title":"Hughes Syndrome","author":"M Petri","year":"2006","unstructured":"Petri, M. in Hughes Syndrome Vol. 1 2nd edition (ed. Khamashta, M. A.) 22\u201328 (Springer, 2006)."},{"key":"BFnrneph201438_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/jaut.2000.0409","volume":"15","author":"M Petri","year":"2000","unstructured":"Petri, M. Epidemiology of the antiphospholipid antibody syndrome. J. Autoimmun. 15, 145\u2013151 (2000).","journal-title":"J. Autoimmun."},{"key":"BFnrneph201438_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/b136178","volume-title":"Hughes Syndrome","author":"M Khamashta","year":"2006","unstructured":"Khamashta, M. in Hughes Syndrome Vol. 1 2nd edition (ed. Khamashta, M. A.) 3\u20138 (Springer, 2006)."},{"key":"BFnrneph201438_CR8","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera, R. et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 46, 1019\u20131027 (2002).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201438_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/0961203310395051","volume":"20","author":"R Cervera","year":"2011","unstructured":"Cervera, R. et al. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus 20, 165\u2013173 (2011).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00002281-200109000-00006","volume":"13","author":"PL Meroni","year":"2001","unstructured":"Meroni, P. L. & Riboldi, P. Pathogenic mechanisms mediating antiphospholipid syndrome. Curr. Opin. Rheumatol. 13, 377\u2013382 (2001).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrneph201438_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMra1112830","volume":"368","author":"B Giannakopoulos","year":"2013","unstructured":"Giannakopoulos, B. & Krilis, S. A. The pathogenesis of the antiphospholipid syndrome. N. Engl. J. Med. 368, 1033\u20131044 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201438_CR12","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/j.1538-7836.2006.02193.x","volume":"4","author":"MJ Cuadrado","year":"2006","unstructured":"Cuadrado, M. J. et al. Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome. J. Thromb. Haemost. 4, 2461\u20132469 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrneph201438_CR13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/rheumatology\/kes388","volume":"52","author":"S Sciascia","year":"2013","unstructured":"Sciascia, S. et al. GAPSS: the global anti-phospholipid syndrome score. Rheumatology (Oxford) 52, 1397\u20131403 (2013).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrneph201438_CR14","first-page":"397","volume":"21","author":"JT Lie","year":"1994","unstructured":"Lie, J. T. Vasculitis in the antiphospholipid syndrome: culprit or consort? J. Rheumatol. 21, 397\u2013399 (1994).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201438_CR15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","volume":"13","author":"E Daugas","year":"2002","unstructured":"Daugas, E. et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J. Am. Soc. Nephrol. 13, 42\u201352 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201438_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.semarthrit.2006.01.001","volume":"35","author":"I Uthman","year":"2006","unstructured":"Uthman, I. & Khamashta, M. Antiphospholipid syndrome and the kidneys. Semin. Arthritis Rheum. 35, 360\u2013367 (2006).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrneph201438_CR17","first-page":"1181","volume":"19","author":"MC Amigo","year":"1992","unstructured":"Amigo, M. C., Garcia-Torres, R., Robles, M., Bochicchio, T. & Reyes, P. A. Renal involvement in primary antiphospholipid syndrome. J. Rheumatol. 19, 1181\u20131185 (1992).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201438_CR18","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.20433","volume":"50","author":"MG Tektonidou","year":"2004","unstructured":"Tektonidou, M. G., Sotsiou, F., Nakopoulou, L., Vlachoyiannopoulos, P. G. & Moutsopoulos, H. M. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum. 50, 2569\u20132579 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201438_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","volume":"10","author":"D Nochy","year":"1999","unstructured":"Nochy, D. et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J. Am. Soc. Nephrol. 10, 507\u2013518 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201438_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/qjmed\/93.7.457","volume":"93","author":"MH Griffiths","year":"2000","unstructured":"Griffiths, M. H., Papadaki, L. & Neild, G. H. The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury. Q. J. Med. 93, 457\u2013467 (2000).","journal-title":"Q. J. Med."},{"key":"BFnrneph201438_CR21","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/ndt\/gfq356","volume":"25","author":"B Alchi","year":"2010","unstructured":"Alchi, B., Griffiths, M. & Jayne, D. What nephrologists need to know about antiphospholipid syndrome. Nephrol. Dial. Transplant. 25, 3147\u20133154 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201438_CR22","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1093\/ndt\/gfs279","volume":"27","author":"T Barbour","year":"2012","unstructured":"Barbour, T., Johnson, S., Cohney, S. & Hughes, P. Thrombotic microangiopathy and associated renal disorders. Nephrol. Dial. Transplant. 27, 2673\u20132685 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201438_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.berh.2012.07.005","volume":"26","author":"S Sciascia","year":"2012","unstructured":"Sciascia, S., Lopez-Pedrera, C., Roccatello, D. & Cuadrado, M. J. Catastrophic antiphospholipid syndrome (CAPS). Best Pract. Res. Clin. Rheumatol. 26, 535\u2013541 (2012).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"BFnrneph201438_CR24","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0272-6386(03)00352-4","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri, F. et al. The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am. J. Kidney Dis. 41, 1205\u20131211 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201438_CR25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2215\/CJN.00460110","volume":"5","author":"RA Sinico","year":"2010","unstructured":"Sinico, R. A. et al. Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin. J. Am. Soc. Nephrol. 5, 1211\u20131217 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201438_CR26","first-page":"724","volume":"92","author":"A Zea Mendoza","year":"1989","unstructured":"Zea Mendoza, A. et al. Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis [Spanish]. Med. Clin. (Barc.) 92, 724\u2013728 (1989).","journal-title":"Med. Clin. (Barc.)"},{"key":"BFnrneph201438_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.ajkd.2003.09.011","volume":"43","author":"G Moroni","year":"2004","unstructured":"Moroni, G. et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am. J. Kidney Dis. 43, 28\u201336 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201438_CR28","first-page":"75","volume":"19","author":"C Fofi","year":"2001","unstructured":"Fofi, C. et al. Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis. Clin. Exp. Rheumatol. 19, 75\u201377 (2001).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrneph201438_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/ard.49.3.184","volume":"49","author":"PA Ostuni","year":"1990","unstructured":"Ostuni, P. A. et al. Renal-artery thrombosis and hypertension in a 13-year-old girl with antiphospholipid syndrome. Ann. Rheum. Dis. 49, 184\u2013187 (1990).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201438_CR30","first-page":"1413","volume":"18","author":"RA Asherson","year":"1991","unstructured":"Asherson, R. A., Noble, G. E. & Hughes, G. R. Hypertension, renal artery stenosis and the \u201cprimary\u201d antiphospholipid syndrome. J. Rheumatol. 18, 1413\u20131415 (1991).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201438_CR31","first-page":"1802","volume":"19","author":"PR Ames","year":"1992","unstructured":"Ames, P. R. et al. Bilateral renal artery occlusion in a patient with primary antiphospholipid antibody syndrome: thrombosis, vasculitis or both? J. Rheumatol. 19, 1802\u20131806 (1992).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201438_CR32","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard.62.10.999","volume":"62","author":"SR Sangle","year":"2003","unstructured":"Sangle, S. R. et al. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann. Rheum. Dis. 62, 999\u20131002 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201438_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12016-008-8112-z","volume":"36","author":"MG Tektonidou","year":"2009","unstructured":"Tektonidou, M. G. Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clin. Rev. Allergy Immunol. 36, 131\u2013140 (2009).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrneph201438_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1081\/CEH-100106823","volume":"23","author":"A Voiculescu","year":"2001","unstructured":"Voiculescu, A. et al. Noninvasive investigation for renal artery stenosis: contrast-enhanced magnetic resonance angiography and color Doppler sonography as compared to digital subtraction angiography. Clin. Exp. Hypertens. 23, 521\u2013531 (2001).","journal-title":"Clin. Exp. Hypertens."},{"key":"BFnrneph201438_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/08860220601166305","volume":"29","author":"C Rountas","year":"2007","unstructured":"Rountas, C. Imaging modalities for renal artery stenosis in suspected renovasuclar hypertension: prospective intraindividual comparison of color Doppler, US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography. Ren. Fail. 29, 295\u2013302 (2007).","journal-title":"Ren. Fail."},{"key":"BFnrneph201438_CR36","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00467-011-1787-z","volume":"26","author":"S Chaturvedi","year":"2011","unstructured":"Chaturvedi, S., Brandao, L., Geary, D. & Licht, C. Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy. Pediatr. Nephrol. 26, 979\u2013985 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201438_CR37","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1001\/archinte.1985.00360080059007","volume":"145","author":"HI Glueck","year":"1985","unstructured":"Glueck, H. I. et al. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch. Intern. Med. 145, 1389\u20131395 (1985).","journal-title":"Arch. Intern. Med."},{"key":"BFnrneph201438_CR38","first-page":"465","volume":"11","author":"RA Asherson","year":"1993","unstructured":"Asherson, R. A., Khamashta, M. A. & Hughes, G. R. Hypertension and the antiphospholipid antibodies. Clin. Exp. Rheumatol. 11, 465\u2013467 (1993).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrneph201438_CR39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/rheumatology\/40.8.863","volume":"40","author":"KE Moss","year":"2001","unstructured":"Moss, K. E. & Isenberg, D. A. Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology (Oxford) 40, 863\u2013867 (2001).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrneph201438_CR40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/0961203311430220","volume":"21","author":"CS Oliveira","year":"2012","unstructured":"Oliveira, C. S. et al. Renal transplantation in lupus nephritis: a Brazilian cohort. Lupus 21, 570\u2013574 (2012).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4137\/CCRep.S11633","volume":"6","author":"B Padilla-Fernandez","year":"2013","unstructured":"Padilla-Fernandez, B. et al. Bilateral renal infarction in a lupus patient: an unusual pathology. Clin. Med. Insights Case Rep. 6, 87\u201391 (2013).","journal-title":"Clin. Med. Insights Case Rep."},{"key":"BFnrneph201438_CR42","first-page":"7","volume":"6","author":"P Scully","year":"2013","unstructured":"Scully, P., Leckstroem, D. C., McGrath, A., Chambers, J. & Goldsmith, D. J. Repeated renal infarction in native and transplanted kidneys due to left ventricular thrombus formation caused by antiphospholipid antibody syndrome. Int. Med. Case Rep. J. 6, 7\u201312 (2013).","journal-title":"Int. Med. Case Rep. J."},{"key":"BFnrneph201438_CR43","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0272-6386(96)90109-2","volume":"27","author":"JM Poux","year":"1996","unstructured":"Poux, J. M. et al. Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome. Am. J. Kidney Dis. 27, 721\u2013725 (1996).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201438_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.revmed.2011.01.006","volume":"32","author":"T Zenone","year":"2011","unstructured":"Zenone, T. & Knefati, Y. Renal infarction in systemic lupus with antiphospholipid syndrome: role of hydroxychloroquine withdrawal? [French] Rev. Med. Interne 32, 261\u2013262 (2011).","journal-title":"Rev. Med. Interne"},{"key":"BFnrneph201438_CR45","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/01.CIR.98.11.1092","volume":"98","author":"J Frostegard","year":"1998","unstructured":"Frostegard, J., Wu, R., Gillis-Haegerstrand, C., Lemne, C. & de Faire, U. Antibodies to endothelial cells in borderline hypertension. Circulation 98, 1092\u20131098 (1998).","journal-title":"Circulation"},{"key":"BFnrneph201438_CR46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1191\/0961203304lu1082oa","volume":"13","author":"C Rollino","year":"2004","unstructured":"Rollino, C. et al. Antiphospholipid antibodies and hypertension. Lupus 13, 769\u2013772 (2004).","journal-title":"Lupus"},{"issue":"Suppl. 3","key":"BFnrneph201438_CR47","first-page":"93","volume":"24","author":"L Ribera","year":"2004","unstructured":"Ribera, L., Vallve, M. & Almirall, J. Primary antiphospholipid syndrome associated with malignant hypertension [Spanish]. Nefrologia 24 (Suppl. 3), 93\u201396 (2004).","journal-title":"Nefrologia"},{"key":"BFnrneph201438_CR48","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1159\/000189092","volume":"73","author":"AE Sirvent","year":"1996","unstructured":"Sirvent, A. E. et al. Malignant hypertension and antiphospholipid syndrome. Nephron 73, 368\u2013369 (1996).","journal-title":"Nephron"},{"key":"BFnrneph201438_CR49","first-page":"479","volume":"11","author":"P Cacoub","year":"1993","unstructured":"Cacoub, P. et al. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis. Clin. Exp. Rheumatol. 11, 479\u2013485 (1993).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrneph201438_CR50","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1136\/ard.2010.142042","volume":"70","author":"A Ruffatti","year":"2011","unstructured":"Ruffatti, A. et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann. Rheum. Dis. 70, 1083\u20131086 (2011).","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 3","key":"BFnrneph201438_CR51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2013-eular.836","volume":"72","author":"C P\u00e9rez Vel\u00e1squez","year":"2013","unstructured":"P\u00e9rez Vel\u00e1squez, C., Isenberg, D. & Croca, S. Secondary antiphospholipid syndrome nephropathy and lupus nephritis: a case-control study [abstract THU0308]. Ann. Rheum. Dis. 72 (Suppl. 3), 270 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201438_CR52","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.2169\/internalmedicine.48.2363","volume":"48","author":"Y Tsuruta","year":"2009","unstructured":"Tsuruta, Y., Uchida, K., Itabashi, M., Yumura, W. & Nitta, K. Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis. Intern. Med. 48, 1875\u20131880 (2009).","journal-title":"Intern. Med."},{"key":"BFnrneph201438_CR53","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3899\/jrheum.100650","volume":"38","author":"T Mehrani","year":"2011","unstructured":"Mehrani, T. & Petri, M. IgM anti-\u03b22 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus. J. Rheumatol. 38, 450\u2013453 (2011).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201438_CR54","first-page":"795","volume":"68","author":"P Kincaid-Smith","year":"1988","unstructured":"Kincaid-Smith, P., Fairley, K. F. & Kloss, M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q. J. Med. 68, 795\u2013815 (1988).","journal-title":"Q. J. Med."},{"key":"BFnrneph201438_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/0971-4065.37021","volume":"17","author":"RN Menon","year":"2007","unstructured":"Menon, R. N. & Bichile. L. S. Study of renal histopathological correlation with anticardiolipin antibody status in patients with systemic lupus erythematosus. Indian J. Nephrol. 17, 53\u201360 (2007).","journal-title":"Indian J. Nephrol."},{"key":"BFnrneph201438_CR56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/qjmed\/91.6.401","volume":"91","author":"S Bhandari","year":"1998","unstructured":"Bhandari, S., Harnden, P., Brownjohn, A. M. & Turney, J. H. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. Q. J. Med. 91, 401\u2013409 (1998).","journal-title":"Q. J. Med."},{"key":"BFnrneph201438_CR57","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJM199504133321504","volume":"332","author":"MA Khamashta","year":"1995","unstructured":"Khamashta, M. A. et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N. Engl. J. Med. 332, 993\u2013997 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201438_CR58","doi-asserted-by":"publisher","unstructured":"Jordan, N. P. et al. Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post renal biopsy in antiphospholipid antibody positive patients. Arthritis Care Res. (Hoboken) http:\/\/dx.doi.org\/10.1002\/acr.22200 (2013).","DOI":"10.1002\/acr.22200"},{"key":"BFnrneph201438_CR59","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/rheumatology\/keg302","volume":"42","author":"NA Dayal","year":"2003","unstructured":"Dayal, N. A. & Isenberg, D. A. Endstage renal failure in primary antiphospholipid syndrome\u2014case report and review of literature. Rheumatology (Oxford) 42, 1128\u20131129 (2003).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrneph201438_CR60","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1399-0012.2012.01625.x","volume":"26","author":"S Vaidya","year":"2012","unstructured":"Vaidya, S. Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome. Clin. Transplant. 26, 853\u2013856 (2012).","journal-title":"Clin. Transplant."},{"key":"BFnrneph201438_CR61","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.rdc.2006.05.004","volume":"32","author":"MC Amigo","year":"2006","unstructured":"Amigo, M. C. Kidney disease in antiphospholipid syndrome. Rheum. Dis. Clin. North Am. 32, 509\u2013522 (2006).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrneph201438_CR62","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0272-6386(12)80383-0","volume":"23","author":"LN Prieto","year":"1994","unstructured":"Prieto, L. N. & Suki, W. N. Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies. Am. J. Kidney Dis. 23, 587\u2013590 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201438_CR63","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ndt\/6.8.543","volume":"6","author":"F Garciamartin","year":"1991","unstructured":"Garciamartin, F. et al. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal-disease. Nephrol. Dial. Transplant. 6, 543\u2013547 (1991).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201438_CR64","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0003-4975(99)00458-0","volume":"68","author":"DR Fastenau","year":"1999","unstructured":"Fastenau, D. R., Wagenknecht, D. R. & McIntyre, J. A. Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients. Ann. Thorac. Surg. 68, 137\u2013142 (1999).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrneph201438_CR65","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1159\/000187422","volume":"64","author":"T Sitter","year":"1993","unstructured":"Sitter, T. & Schiffl, H. Anticardiolipin antibodies in patients on regular hemodialysis: an epiphenomenon? Nephron 64, 655\u2013656 (1993).","journal-title":"Nephron"},{"key":"BFnrneph201438_CR66","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.transproceed.2004.12.151","volume":"37","author":"S Vaidya","year":"2005","unstructured":"Vaidya, S. Management of end-stage renal disease patients with antiphospholipid antibody syndrome. Transplant. Proc. 37, 650\u2013651 (2005).","journal-title":"Transplant. Proc."},{"key":"BFnrneph201438_CR67","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0049-3848(93)90212-7","volume":"72","author":"J Matsuda","year":"1993","unstructured":"Matsuda, J. et al. \u03b2-2-glycoprotein I-dependent and I-independent anticardiolipin antibody in patients with end-stage renal-disease. Thromb. Res. 72, 109\u2013117 (1993).","journal-title":"Thromb. Res."},{"key":"BFnrneph201438_CR68","first-page":"434","volume":"89","author":"B Ferlazzo","year":"1998","unstructured":"Ferlazzo, B. et al. Anticardiolipin antibodies in hemodialysis patients and in renal transplant recipients: prevalence and significance [Italian]. Recenti Prog. Med. 89, 434\u2013437 (1998).","journal-title":"Recenti Prog. Med."},{"key":"BFnrneph201438_CR69","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF01698134","volume":"65","author":"T Sitter","year":"1992","unstructured":"Sitter, T., Spannagl, M. & Schiffl, H. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann. Hematol. 65, 79\u201382 (1992).","journal-title":"Ann. Hematol."},{"key":"BFnrneph201438_CR70","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000187511","volume":"65","author":"AO Phillips","year":"1993","unstructured":"Phillips, A. O., Jones, H. W., Hambley, H., Hillis, A. N. & Hendry, B. M. Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients. Nephron 65, 350\u2013353 (1993).","journal-title":"Nephron"},{"key":"BFnrneph201438_CR71","first-page":"193","volume":"72","author":"S Ozmen","year":"2009","unstructured":"Ozmen, S., Danis, R., Akin, D. & Batun, S. Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure. Clin. Nephrol. 72, 193\u2013198 (2009).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph201438_CR72","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/01.MAT.0000154691.85595.9D","volume":"51","author":"F Gultekin","year":"2005","unstructured":"Gultekin, F. et al. The relationship between anticardiolipin antibodies and vascular access occlusion in patients on hemodialysis. ASAIO J. 51, 162\u2013164 (2005).","journal-title":"ASAIO J."},{"key":"BFnrneph201438_CR73","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1023\/B:UROL.0000020354.61227.40","volume":"35","author":"R Jamshid","year":"2003","unstructured":"Jamshid, R., Reza, S. A., Abbas, G. & Raha, A. Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients. Int. Urol. Nephrol. 35, 275\u2013282 (2003).","journal-title":"Int. Urol. Nephrol."},{"key":"BFnrneph201438_CR74","first-page":"428","volume":"56","author":"S Adler","year":"2001","unstructured":"Adler, S., Szczech, L., Qureshi, A., Bollu, R. & Thomas-John, R. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis. Clin. Nephrol. 56, 428\u2013434 (2001).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph201438_CR75","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1159\/000045833","volume":"86","author":"YS Haviv","year":"2000","unstructured":"Haviv, Y. S. Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: cause or effect? Nephron 86, 447\u2013454 (2000).","journal-title":"Nephron"},{"key":"BFnrneph201438_CR76","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0272-6386(95)90656-8","volume":"26","author":"R Prakash","year":"1995","unstructured":"Prakash, R., Miller, C. C. 3rd & Suki, W. N. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am. J. Kidney Dis. 26, 347\u2013352 (1995).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201438_CR77","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/ndt\/7.12.1194","volume":"7","author":"SL Chew","year":"1992","unstructured":"Chew, S. L. et al. Are antiphospholipid antibodies clinically relevant in dialysis patients? Nephrol. Dial. Transplant. 7, 1194\u20131198 (1992).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201438_CR78","first-page":"2817","volume":"27","author":"D Erkan","year":"2000","unstructured":"Erkan, D., Yazici, Y., Sobel, R. & Lockshin, M. D. Primary antiphospholipid syndrome: functional outcome after 10 years. J. Rheumatol. 27, 2817\u20132821 (2000).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201438_CR79","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00467-004-1491-3","volume":"19","author":"L Butani","year":"2004","unstructured":"Butani, L. End-stage renal disease from glomerulonephritis associated with anti-phospholipid syndrome. Pediatr. Nephrol. 19, 812\u2013814 (2004).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201438_CR80","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ki.2011.477","volume":"81","author":"A Serrano","year":"2012","unstructured":"Serrano, A. et al. IgA antibodies against \u03b22 glycoprotein I in hemodialysis patients are an independent risk factor for mortality. Kidney Int. 81, 1239\u20131244 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201438_CR81","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.autrev.2012.08.002","volume":"12","author":"H Meijide","year":"2013","unstructured":"Meijide, H., Sciascia, S., Sanna, G., Khamashta, M. A. & Bertolaccini, M. L. The clinical relevance of IgA anticardiolipin and IgA anti-\u03b22 glycoprotein I antiphospholipid antibodies: a systematic review. Autoimmun. Rev. 12, 421\u2013425 (2013).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneph201438_CR82","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S0272-6386(99)70009-0","volume":"34","author":"JH Stone","year":"1999","unstructured":"Stone, J. H., Amend, W. J. C. & Criswell, L. A. Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in96 consecutive patients with systemic lupus erythematosus. Am. J. Kidney Dis. 34, 1040\u20131047 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201438_CR83","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0041-1345(98)01629-7","volume":"31","author":"DR Wagenknecht","year":"1999","unstructured":"Wagenknecht, D. R. et al. Antiphospholipid antibodies are a risk factor for early renal allograft failure: isolation of antiphospholipid antibodies from a thrombosed renal allograft. Transplant. Proc. 31, 285\u2013288 (1999).","journal-title":"Transplant. Proc."},{"key":"BFnrneph201438_CR84","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00007890-199907270-00014","volume":"68","author":"DR Wagenknecht","year":"1999","unstructured":"Wagenknecht, D. R., Becker, D. G., LeFor, W. M. & McIntyre, J. A. Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation 68, 241\u2013246 (1999).","journal-title":"Transplantation"},{"key":"BFnrneph201438_CR85","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1191\/0961203303lu401oa","volume":"12","author":"JA McIntyre","year":"2003","unstructured":"McIntyre, J. A. & Wagenknecht, D. R. Antiphospholipid antibodies and renal transplantation: a risk assessment. Lupus 12, 555\u2013559 (2003).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR86","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00007890-199901150-00015","volume":"67","author":"D Ducloux","year":"1999","unstructured":"Ducloux, D. et al. Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. Transplantation 67, 90\u201393 (1999).","journal-title":"Transplantation"},{"key":"BFnrneph201438_CR87","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11926-000-0089-4","volume":"2","author":"MC Amigo","year":"2000","unstructured":"Amigo, M. C. & Garcia-Torres, R. Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis. Curr. Rheumatol. Rep. 2, 262\u2013270 (2000).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrneph201438_CR88","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1111\/j.1600-6143.2010.03233.x","volume":"10","author":"G Canaud","year":"2010","unstructured":"Canaud, G. et al. Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies. Am. J. Transplant. 10, 2051\u20132060 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201438_CR89","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1016\/j.transproceed.2005.10.049","volume":"37","author":"G Fern\u00e1ndez-Fresnedo","year":"2005","unstructured":"Fern\u00e1ndez-Fresnedo, G. et al. Clinical significance of antiphospholipid antibodies on allograft and patient outcome after kidney transplantation. Transplant. Proc. 37, 3710\u20133711 (2005).","journal-title":"Transplant. Proc."},{"key":"BFnrneph201438_CR90","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.2215\/CJN.00240110","volume":"5","author":"A Smyth","year":"2010","unstructured":"Smyth, A. et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin. J. Am. Soc. Nephrol. 5, 2060\u20132068 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201438_CR91","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1517\/13543784.11.6.819","volume":"11","author":"R Isom","year":"2002","unstructured":"Isom, R., Nickolas, T. L. & Radhakrishnan, J. Nephrological and obstetric complications of the antiphospholipid syndrome. Expert Opin. Investig. Drugs 11, 819\u2013829 (2002).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"BFnrneph201438_CR92","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4103\/1319-2442.111064","volume":"24","author":"VS Vellanki","year":"2013","unstructured":"Vellanki, V. S. et al. Post-partum bilateral renal cortical necrosis in antiphospholipid syndrome and systemic lupus erythematosus. Saudi J. Kidney Dis. Transpl. 24, 549\u2013552 (2013).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"BFnrneph201438_CR93","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1177\/0961203313504637","volume":"22","author":"O Ateka-Barrutia","year":"2013","unstructured":"Ateka-Barrutia, O. & Khamashta, M. A. The challenge of pregnancy for patients with SLE. Lupus 22, 1295\u20131308 (2013).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR94","unstructured":"National Institute for Health and Clinical Excellence. CG107 Hypertension in pregnancy: the management of hypertensive disorders during pregnancy [online] , (2014)."},{"key":"BFnrneph201438_CR95","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/15733971113099990003","volume":"9","author":"I Rodr\u00edguez-Pint\u00f3","year":"2013","unstructured":"Rodr\u00edguez-Pint\u00f3, I., Espinosa, G. & Cervera, R. Catastrophic antiphospholipid syndrome\u201420 years later. Curr. Rheumatol. Rev. 9, 73\u201380 (2013).","journal-title":"Curr. Rheumatol. Rev."},{"key":"BFnrneph201438_CR96","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/0961203312436866","volume":"21","author":"R Cervera","year":"2012","unstructured":"Cervera, R. CAPS Registry. Lupus 21, 755\u2013757 (2012).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR97","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","volume":"32","author":"R Cervera","year":"2009","unstructured":"Cervera, R. et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry\u201d. J. Autoimmun. 32, 240\u2013245 (2009).","journal-title":"J. Autoimmun."},{"key":"BFnrneph201438_CR98","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.autrev.2006.06.009","volume":"6","author":"R Cervera","year":"2006","unstructured":"Cervera, R., Espinosa, G., Bucciarelli, S., Gomez-Puerta, J. A. & Font, J. Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry. Autoimmun. Rev. 6, 81\u201384 (2006).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneph201438_CR99","first-page":"1983","volume":"35","author":"MG Tektonidou","year":"2008","unstructured":"Tektonidou, M. G., Sotsiou, F. & Moutsopoulos, H. M. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. J. Rheumatol. 35, 1983\u20131988 (2008).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201438_CR100","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/0961203310395803","volume":"20","author":"G Ruiz-Irastorza","year":"2011","unstructured":"Ruiz-Irastorza, G. et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus 20, 206\u2013218 (2011).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR101","doi-asserted-by":"publisher","unstructured":"Erkan, D. et al. 14th International Congress on Antiphospholipid Antibodies Task Force report on antiphospholipid syndrome treatment trends. Autoimmun. Rev. http:\/\/dx.doi.org\/10.1016\/j.autrev.2014.01.053 (2014).","DOI":"10.1016\/j.autrev.2014.01.053"},{"key":"BFnrneph201438_CR102","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","volume":"118","author":"V Pengo","year":"2011","unstructured":"Pengo, V. et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood 118, 4714\u20134718 (2011).","journal-title":"Blood"},{"key":"BFnrneph201438_CR103","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1111\/jth.12014","volume":"10","author":"S Sciascia","year":"2012","unstructured":"Sciascia, S. et al. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities. J. Thromb. Haemost. 10, 2512\u20132518 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"BFnrneph201438_CR104","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/0961203312445229","volume":"21","author":"MT Bertero","year":"2012","unstructured":"Bertero, M. T. Primary prevention in antiphospholipid antibody carriers. Lupus 21, 751\u2013754 (2012).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR105","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2008.101766","volume":"69","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P. & Khamashta, M. A. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann. Rheum. Dis. 69, 20\u201328 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201438_CR106","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.autrev.2011.04.030","volume":"10","author":"T Scoble","year":"2011","unstructured":"Scoble, T., Wijetilleka, S. & Khamashta, M. A. Management of refractory anti-phospholipid syndrome. Autoimmun. Rev. 10, 669\u2013673 (2011).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneph201438_CR107","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","volume":"376","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza, G., Crowther, M., Branch, W. & Khamashta, M. A. Antiphospholipid syndrome. Lancet 376, 1498\u20131509 (2010).","journal-title":"Lancet"},{"key":"BFnrneph201438_CR108","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/096120330000900112","volume":"9","author":"GI Remondino","year":"2000","unstructured":"Remondino, G. I. et al. A reversible bilateral renal artery stenosis in association with antiphospholipid syndrome. Lupus 9, 65\u201367 (2000).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR109","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/rheumatology\/keh490","volume":"44","author":"SR Sangle","year":"2005","unstructured":"Sangle, S. R., D'Cruz, D. P., Abbs, I. C., Khamashta, M. A. & Hughes, G. R. Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Rheumatology (Oxford) 44, 372\u2013377 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrneph201438_CR110","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3899\/jrheum.120157","volume":"40","author":"A Broder","year":"2013","unstructured":"Broder, A. & Putterman, C. Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and\/or lupus anticoagulant in systemic lupus erythematosus. J. Rheumatol. 40, 30\u201333 (2013).","journal-title":"J. Rheumatol."},{"key":"BFnrneph201438_CR111","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/0961203311400115","volume":"20","author":"S Sciascia","year":"2011","unstructured":"Sciascia, S., Naretto, C., Rossi, D., Bazzan, M. & Roccatello, D. Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome. Lupus 20, 1106\u20131108 (2011).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR112","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1191\/0961203303lu461oa","volume":"12","author":"C Korkmaz","year":"2003","unstructured":"Korkmaz, C., Kabukcuoglu, S., Isiksoy, S. & Yalcin, A. U. Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy. Lupus 12, 760\u2013765 (2003).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR113","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1681\/ASN.V4128","volume":"4","author":"DOB Sokunbi","year":"1993","unstructured":"Sokunbi, D. O. B., Miller, F., Wadhwa, N. K. & Nord, E. P. Reversible renal-failure in the primary antiphospholipid syndrome\u2014a report of 2 cases. J. Am. Soc. Nephrol. 4, 28\u201335 (1993).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201438_CR114","first-page":"409","volume":"30","author":"S Sciascia","year":"2012","unstructured":"Sciascia, S., Giachino, O. & Roccatello, D. Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin. Clin. Exp. Rheumatol. 30, 409\u2013413 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrneph201438_CR115","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11926-013-0331-5","volume":"15","author":"DJ Arachchillage","year":"2013","unstructured":"Arachchillage, D. J. & Cohen, H. Use of new oral anticoagulants in antiphospholipid syndrome. Curr. Rheumatol. Rep. 15, 331 (2013).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrneph201438_CR116","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1177\/0961203312458843","volume":"21","author":"I Giles","year":"2012","unstructured":"Giles, I., Khamashta, M., D'Cruz, D. & Cohen, H. A new dawn of anticoagulation for patients with antiphospholipid syndrome? Lupus 21, 1263\u20131265 (2012).","journal-title":"Lupus"},{"key":"BFnrneph201438_CR117","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/art.37759","volume":"65","author":"D Erkan","year":"2013","unstructured":"Erkan, D., Vega, J., Ramon, G., Kozora, E. & Lockshin, M. D. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum. 65, 464\u2013471 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201438_CR118","first-page":"160","volume":"5","author":"D Erkan","year":"2009","unstructured":"Erkan, D. & Lockshin, M. D. New approaches for managing antiphospholipid syndrome. Nat. Clin. Pract. Rheumatol. 5, 160\u2013170 (2009).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"BFnrneph201438_CR119","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1177\/0961203310389099","volume":"20","author":"C Velik-Salchner","year":"2011","unstructured":"Velik-Salchner, C., Lederer, W. & Wiedermann, F. Eculizumab and renal transplantation in a patient with catastrophic antiphospholipid syndrome: effect of heparin on complement activation. Lupus 20, 772 (2011).","journal-title":"Lupus"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2014.38.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2014.38","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2014.38.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:44:44Z","timestamp":1746153884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2014.38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,18]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["BFnrneph201438"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2014.38","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,18]]}}}